PATENT CLAIM ANALYSIS

Application Number: 15758787
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["540", "560000"]

Abstract:
The present invention provides compounds of Formula (I), and pharmaceutically compositions thereof. Compounds of Formula (I) are binders of bromodomains and/or bromodomain-containing proteins (e.g., bromo and extra terminal (BET) proteins). Also provided are methods, uses, and kits using the compounds and pharmaceutical compositions for inhibiting the activity (e.g., increased activity) of bromodomains and/or bromodomain containing proteins and for treating and/or preventing in a subject diseases associated with bromodomains or bromodomain-containing proteins (e.g., proliferative diseases, cardiovascular diseases, viral infections, fibrotic diseases, metabolic diseases, endocrine diseases, and radiation poisoning). The compounds, pharmaceutical compositions, and kits are also useful for male contraception.

Claim (Index 56):
A method of inducing apoptosis in a cell in a subject, the method comprising administering to the subject an effective amount of a compound of  claim 1 , or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 2.01562
- Patent Class: 540.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15426708', '15114895', '15847430', '15104132', '15904143']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.718091093639825
- 35 USC 102 Novelty (BERT): 0.5610150988556072
- Combined Prediction Score: 0.7023834941614033
- Mean Citation Score: 424.973546
- Max Citation Score: 443.95645
- Similarity Product: 343.1100386193484

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test